168 related articles for article (PubMed ID: 16163218)
1. SRC as a potential therapeutic target in solid tumor oncology.
Gallick GE
Clin Adv Hematol Oncol; 2004 Jul; 2(7):435-7. PubMed ID: 16163218
[No Abstract] [Full Text] [Related]
2. SRC as a target for anti-cancer drugs.
Levitzki A
Anticancer Drug Des; 1996 Apr; 11(3):175-82. PubMed ID: 8663905
[No Abstract] [Full Text] [Related]
3. Epidermal growth factor receptor inhibitors: current status and future directions.
Chen HX; Cleck JN; Coelho R; Dancey JE
Curr Probl Cancer; 2009; 33(4):245-94. PubMed ID: 20082842
[No Abstract] [Full Text] [Related]
4. The role of Src in solid and hematologic malignancies: development of new-generation Src inhibitors.
Alvarez RH; Kantarjian HM; Cortes JE
Cancer; 2006 Oct; 107(8):1918-29. PubMed ID: 16986126
[TBL] [Abstract][Full Text] [Related]
5. Novel aminomethylindole derivatives as inhibitors of pp60c-Src tyrosine kinase: synthesis and biological activity.
Işgör YG; Kiliç Z; Olgen S
Chem Biol Drug Des; 2008 Dec; 72(6):599-604. PubMed ID: 19090928
[TBL] [Abstract][Full Text] [Related]
6. Introduction: targeting different pathways to prevent tumor cell development.
Kantarjian HM
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S1-5. PubMed ID: 19393830
[No Abstract] [Full Text] [Related]
7. Novel therapeutic targets.
Farley J; Birrer MJ
Cancer Treat Res; 2009; 149():63-84. PubMed ID: 19763431
[No Abstract] [Full Text] [Related]
8. Novel apoptosis inducing agents in cancer therapy.
Mita M; Tolcher AW
Curr Probl Cancer; 2005; 29(1):8-32. PubMed ID: 15672328
[No Abstract] [Full Text] [Related]
9. Protein kinases: From targets to anti-cancer drugs.
Cruzalegui F
Ann Pharm Fr; 2010 Jul; 68(4):254-9. PubMed ID: 20637357
[TBL] [Abstract][Full Text] [Related]
10. Current management of GIST.
Blanke C
Clin Adv Hematol Oncol; 2004 May; 2(5):280, 283. PubMed ID: 17682286
[No Abstract] [Full Text] [Related]
11. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
Coluccia AM; Benati D; Dekhil H; De Filippo A; Lan C; Gambacorti-Passerini C
Cancer Res; 2006 Feb; 66(4):2279-86. PubMed ID: 16489032
[TBL] [Abstract][Full Text] [Related]
12. Targeting protein kinases in cancer therapy: a success?
Pearson MA; Fabbro D
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1113-24. PubMed ID: 15606337
[TBL] [Abstract][Full Text] [Related]
13. EGFR as a target: rationale for therapy.
Wujcik D
Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):5-9. PubMed ID: 16616281
[TBL] [Abstract][Full Text] [Related]
14. EGFR targeting therapies: monoclonal antibodies versus tyrosine kinase inhibitors. Similarities and differences.
Dassonville O; Bozec A; Fischel JL; Milano G
Crit Rev Oncol Hematol; 2007 Apr; 62(1):53-61. PubMed ID: 17324578
[TBL] [Abstract][Full Text] [Related]
15. Targeted cancer therapy: promise and reality.
Klein S; Levitzki A
Adv Cancer Res; 2007; 97():295-319. PubMed ID: 17419951
[TBL] [Abstract][Full Text] [Related]
16. Predictive biomarkers in the development of oncology drugs: a therapeutic industry perspective.
Fine BM; Amler L
Clin Pharmacol Ther; 2009 May; 85(5):535-8. PubMed ID: 19295504
[No Abstract] [Full Text] [Related]
17. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.
Erman M
J BUON; 2007 Sep; 12 Suppl 1():S83-94. PubMed ID: 17935283
[TBL] [Abstract][Full Text] [Related]
18. On or off target: mutations, models, and predictions.
Garraway LA; Hahn WC
Sci Transl Med; 2010 Jun; 2(35):35ps28. PubMed ID: 20538617
[TBL] [Abstract][Full Text] [Related]
19. Biomarker targets and novel therapeutics.
Clouser M; Hess LM; Chambers SK
Cancer Treat Res; 2009; 149():85-105. PubMed ID: 19763432
[No Abstract] [Full Text] [Related]
20. SRC inhibitors in metastatic bone disease.
Boyce BF; Xing L; Yao Z; Yamashita T; Shakespeare WC; Wang Y; Metcalf CA; Sundaramoorthi R; Dalgarno DC; Iuliucci JD; Sawyer TK
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6291s-6295s. PubMed ID: 17062716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
